Table 1.
Prognosis analysis of immune checkpoints in KIRC.
| Genes | Overall Survival | Progression Free Survival | Disease Free Survival | |||
|---|---|---|---|---|---|---|
| p-value | HR (95%CI) | p-value | HR (95%CI) | p-value | HR (95%CI) | |
| SIGLEC15 | 0.928 | 1.01 (0.75-1.37) | 0.375 | 0.87 (0.63-1.19) | 0.862 | 0.97 (0.66-1.41) |
| CD274 | 0.024 | 0.71 (0.52-0.96) | 0.024 | 0.70 (0.51-0.96) | 0.0092 | 0.60 (0.41-0.89) |
| HAVCR2 | 0.0098 | 0.67 (0.50-0.91) | 0.0046 | 0.63 (0.46-0.87) | 0.0046 | 0.58 (0.39-0.85) |
| PDCD1 | 0.199 | 1.22 (0.90-1.64) | 0.092 | 1.31 (0.96-1.79) | 0.087 | 1.40 (0.95-2.05) |
| CTLA4 | 0.019 | 1.43 (1.06-1.93) | 0.0012 | 1.68 (1.22-2.32) | 0.00098 | 1.84 (1.25-2.72) |
| LAG3 | 0.017 | 1.44 (1.07-1.95) | 0.075 | 1.33 (0.97-1.82) | 0.014 | 1.64 (1.11-2.43) |
| PDCD1LG2 | 0.151 | 0.80 (0.59-1.08) | 0.227 | 0.82 (0.60-1.13) | 0.211 | 0.78 (0.54-1.15) |
| TIGIT | 0.186 | 1.22 (0.91-1.65) | 0.14 | 1.27 (0.92-1.73) | 0.096 | 1.11 (0.83-1.52) |